MENLO PARK, Calif.–(BUSINESS WIRE)–Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today that its management team will be attending the Piper Sandler 37th Annual Healthcare Conference and presenting on Thursday, December 4, 2025, at 9:10 AM EST at The Lotte New York Palace in New York, NY.
About Octave Bioscience, Inc.
Octave Bioscience, Inc. is a commercial stage precision care company pioneering biomarker-driven solutions for neurodegenerative diseases, with initial focus on Multiple Sclerosis, and Parkinson’s Disease in partnership with Michael J. Fox Foundation. Octave’s comprehensive testing solutions provide objective, actionable insights to improve disease monitoring, treatment decisions, and patient outcomes. For more information, visit www.octavebio.com.
Contacts
Caroline Corner
ICR Healthcare
[email protected]
